EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MMP11 as a Prognostic Indicator for Inverted Papilloma Histologic Grade and Recurrence

Kush Panara, Jadyn Wilensky, Alan D Workman, David K Lerner, Alexandria L Irace, Jennifer E Douglas iD, James N Palmer, Nithin D Adappa, Jalal Jalaly, Charles C L Tong iD, Noam A Cohen, Michael A Kohanski

The Laryngoscope · 2026

DOI: 10.1002/lary.70072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2026. Verfasst von Kush Panara und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Papilloma, Inverted, Matrix Metalloproteinase 11, Paranasal Sinus Neoplasms. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Rhinologic Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Inverted papilloma (IP) is a benign, but locally aggressive sinonasal tumor with a high recurrence rate and potential for malignant transformation into squamous cell carcinoma ex‐IP (SCC). Currently, no reliable biomarkers exist to predict recurrence or severity. Matrix metalloproteinase‐11 (MMP11) has been implicated in tumor progression and extracellular matrix remodeling in various malignancies and has been shown to be progressively upregulated in IP transformation. This study investigates the relationship between MMP11 expression and IP histologic severity and recurrence risk.

Methods

Patient demographics and tumor characteristics were collected retrospectively at a tertiary care center from 2008 to 2023. Patient specimens were categorized into normal sinus tissue (NST), IP without dysplasia (IPND), IP with severe dysplasia (IPSD), and SCC. Immunohistochemical staining for MMP11 was performed, and quantitative analysis was conducted using DAB‐Quant software.

Results

A total of 52 patients were included, with a mean follow‐up of 68.8 months. MMP11 expression was significantly elevated in IPSD and SCC compared to IPND (36.7% and 36.5% vs. 21.1%, p = 0.02 and p = 0.01). Patients with recurrence exhibited higher MMP11 expression in their initial resection specimens compared to non‐recurrent cases (31.1% vs. 18.1%, p < 0.01). High MMP11 expression (> 50%) was associated with a shorter time to recurrence (17.5 vs. 32 months, p = 0.03), independent of histologic grade.

Conclusion

MMP11 expression correlates with increased IP histologic grade, risk of recurrence, and shorter time to recurrence. Elevated MMP11 expression may identify patients at higher risk for recurrence, allowing for targeted surveillance strategies and treatment options. Level of Evidence 3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm Recurrence, LocalPapilloma, InvertedMatrix Metalloproteinase 11Paranasal Sinus NeoplasmsHumansFemaleMaleMiddle AgedRetrospective StudiesPrognosisAgedNeoplasm GradingBiomarkers, TumorAdult

Stichwörter der Autor:innen

inverted papillomamatrix metalloproteinase‐11recurrence

Substanzen

Matrix Metalloproteinase 11Biomarkers, TumorMMP11 protein, human

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Otolaryngology, Massachusetts Eye and Ear/Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Otolaryngology, University of Miami, Miami, Florida, USA.
  • Monell Chemical Senses Institute, Philadelphia, Pennsylvania, USA.
  • Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Otolaryngology- Head and Neck Surgery, Lenox Hill Hospital/Long Island Jewish Hospital, New York, New York, USA.

ORCID-Profile: Jennifer E Douglas, Charles C L Tong

Förderung

  • American Rhinologic Society

Zitieren

APA

Panara, K., Wilensky, J., Workman, A. D., Lerner, D. K., Irace, A. L., Douglas, J. E., Palmer, J. N., Adappa, N. D., Jalaly, J., Tong, C. C. L., Cohen, N. A., & Kohanski, M. A. (2026). MMP11 as a Prognostic Indicator for Inverted Papilloma Histologic Grade and Recurrence. The Laryngoscope. https://doi.org/10.1002/lary.70072

Vancouver

Panara K, Wilensky J, Workman AD, Lerner DK, Irace AL, Douglas JE, et al. MMP11 as a Prognostic Indicator for Inverted Papilloma Histologic Grade and Recurrence. The Laryngoscope. 2026. doi:10.1002/lary.70072

BibTeX
@article{Panara2026,
  author = {Panara, Kush and Wilensky, Jadyn and Workman, Alan D and Lerner, David K and Irace, Alexandria L and Douglas, Jennifer E and Palmer, James N and Adappa, Nithin D and Jalaly, Jalal and Tong, Charles C L and Cohen, Noam A and Kohanski, Michael A},
  title = {MMP11 as a Prognostic Indicator for Inverted Papilloma Histologic Grade and Recurrence},
  journal = {The Laryngoscope},
  year = {2026},
  doi = {10.1002/lary.70072}
}
Kostenlos starten →